Buy Crypto Markets Spot FuturesBTC Earn Event Center Rewards Hub

Alzamend Neuro, Inc. (ALZN)

NASDAQ

$1.65

$+0.01

(+0.29%)

Previous Close: ⁦$1.70⁩

Market Closed

Alzamend Neuro, Inc. (ALZN) Live Price Chart

Last updated: ⁦2026-09-05 22:46:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Alzamend Neuro, Inc. (ALZN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.65, with a market capitalization of $8.20M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.84 to $2.68. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$8.20M
Open	$1.70
Day's High	$45,292.50
Day's Low	$0.84
Previous Close	$1.70
Volume	62.64K
Average Volume	--
P/E Ratio	--
52-Week High	$2.68
52-Week Low	$0.84
Dividend Yield	--
Earnings Date	--

Alzamend Neuro, Inc. (ALZN) Latest Closing Stock Price

Alzamend Neuro, Inc. (ALZN) last closed at $1.70 as of 2026-09-04 22:23:00, unchanged from the previous close of $1.70.

During the latest regular trading session, ALZN traded between $0.84 and $45,292.50, with a volume of 62.64K shares. The closing price was near the lower end and near the middle of its 52-week range.

Alzamend Neuro, Inc. (ALZN) 7-Day Stock Price Change

Over the past seven days, Alzamend Neuro, Inc. (ALZN) moved from $1.66 to $1.65, representing a decline of 0.18% ($0.00).

The stock traded between $1.65 and $1.73 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.

The average daily volume was 90.81 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ALZN 52-Week Price Position

Position in Range: 44.1%

52W Low$0.84

52W High$2.68

ALZN is currently trading at $1.65, placing it 44.1% of the way from its 52-week low of $0.84 to its 52-week high of $2.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Alzamend Neuro, Inc. (ALZN)?

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.

Alzamend Neuro, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	6
Exchange	NASDAQ
Company Website	https://www.alzamend.com

How to Buy Alzamend Neuro, Inc. (ALZN) Stock on MEXC

Eligible investors can buy real shares of Alzamend Neuro, Inc. (ALZN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ALZN and Place Your Order

Open the RealStocks trading page and search for ALZN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Alzamend Neuro, Inc. (ALZN) stock price today?

Alzamend Neuro, Inc. (ALZN) is currently trading at $ 1.65, down 2.82% ($0.05) from the previous close of $ 1.70. Intraday prices update in real time during regular trading hours.

2.Is ALZN stock going up or down today?

As of 2026-09-04 22:23:00, ALZN is trading at $ 1.65, down 2.82% ($0.05) from its previous close of $ 1.70. The stock has traded between $ 0.84 and $ 45,292.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is ALZN pre-market price?

As of 2026-09-04 22:23:00, ALZN is trading at $ 1.68 in pre-market trading, down 1.00% ($0.02) from the previous close of $ 1.70. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ALZN after-hours price?

As of 2026-09-04 22:23:00, ALZN is trading at $ 1.69 in after-hours trading, down 0.88% ($0.01) from the regular-session close of $ 1.70. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ALZN stock trading now?

ALZN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ALZN sit relative to its 52-week high and low?

Over the past 52 weeks, ALZN has traded between a low of $ 0.84 and a high of $ 2.68. At $ 1.65, the stock is positioned 44.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Alzamend Neuro, Inc. in?

Alzamend Neuro, Inc. (ALZN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Alzamend Neuro, Inc.'s market capitalization and where is it listed?

Alzamend Neuro, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 8.20M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ALZN valued in terms of P/E ratio and EPS?

ALZN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.82. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Alzamend Neuro, Inc. pay a dividend?

Alzamend Neuro, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.